首页> 外文OA文献 >Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study

【2h】

Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study

机译：BMN 110（依法硫酸法）酶替代疗法对Morquio A综合征（黏多糖贮积症IVA）的疗效和安全性：3期随机安慰剂对照研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Christian J. Hendriksz; null null; Barbara Burton; Thomas R. Fleming; Paul Harmatz; Derralynn Hughes; Simon A. Jones; Shuan-Pei Lin; Eugen Mengel; Maurizio Scarpa; Vassili Valayannopoulos; Roberto Giugliani; Peter Slasor; Debra Lounsbury; Wolfgang Dummer;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study [J] . HendrikszC.J., BurtonB., FlemingT.R., Journal of inherited metabolic disease . 2014,第6期

机译：BMN 110（依法硫酸法）酶替代疗法对Morquio A综合征（黏多糖贮积症IVA）的疗效和安全性：一项3期随机安慰剂对照研究
2. Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study [J] . HendrikszC.J., BurtonB., FlemingT.R., Journal of inherited metabolic disease . 2014,第6期

机译：酶替代治疗对Morquio的酶替代疗法的功效和安全性Morquio A综合征（粘多糖尿病IVA）：第3期随机安慰剂对照研究
3. Safety, immunogenicity, and clinical outcomes in patients with Morquio A syndrome participating in 2 sequential open-label studies of elosulfase alfa enzyme replacement therapy (MOR-002/MOR-100), representing 5 years of treatment [J] . Hendriksz Christian, Santra Saikat, Jones Simon A., Molecular genetics and metabolism . 2018,第4期

机译：Morquio A综合征患者的安全性，免疫原性和临床结果参与了Elosulfase Alfa酶替代疗法（Mor-002 / Mor-100）的2个顺序开放标签研究，代表了5年的治疗方法
4. Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study [O] . Christian J. Hendriksz, Barbara Burton, Thomas R. Fleming, -1

机译：BMN 110（依法硫酸法）酶替代疗法对Morquio A综合征（黏多糖贮积症IVA）的疗效和安全性：3期随机安慰剂对照研究
5. Elosulfase alfa (BMN 110) for the treatment of Mucopolysaccharidosis IVA (Morquio A syndrome) [O] . Hendriksz, Christian J. 2016

机译：用于治疗粘多糖贮积症IVa（morquio a综合征）的Elosulfase alfa（BmN 110）

Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study

著录项

引文网络

相似文献

相关主题

期刊订阅